Thymosin beta-4 is a naturally occurring 43-amino acid polypeptide that functions as a major monomeric actin-sequestering molecule in eukaryotic cells. TB-500 represents a synthetic peptide fragment corresponding to the active actin-binding domain of thymosin beta-4. Both compounds are widely evaluated in preclinical research regarding cell motility, cytoskeletal dynamics, and tissue remodeling.
While frequently grouped together in general discussions, thymosin beta-4 and TB-500 are distinct chemical entities with different molecular weights and amino acid lengths. Understanding these structural differences is essential for designing accurate in vitro experiments.
This article details the sequence characteristics, actin sequestration mechanisms, and preclinical research applications of thymosin beta-4 and TB-500.
Molecular structures of thymosin beta-4 and TB-500
Analyzing primary sequences highlights the structural distinctions between the full-length protein and the synthetic fragment.
Full-length thymosin beta-4 structure
Thymosin beta-4 is a 43-amino acid protein with a theoretical molecular weight of approximately 4963 Da. It contains an N-terminal acetylated serine residue and flanking contact sites that stabilize 1:1 binding with monomeric G-actin.
Synthetic TB-500 fragment structure
TB-500 refers to a truncated synthetic peptide fragment containing the core hexapeptide motif LKKTET (residues 17 to 22 of thymosin beta-4). This synthetic fragment possesses a lower molecular weight while retaining the primary actin-binding site.
Actin sequestration and cell motility mechanics
Actin exists in dynamic equilibrium between monomeric globular actin (G-actin) and polymeric filamentous actin (F-actin). Cytoskeletal remodeling relies on controlled actin assembly.
G-actin sequestering mechanism
Full-length thymosin beta-4 binds G-actin in a 1:1 stoichiometric complex through its LKKTET motif and extended amino-terminal contacts. Sequestering G-actin prevents spontaneous polymerization, maintaining an unpolymerized actin pool necessary for cell elongation and directional migration.
Endothelial cell sprouting and lamellipodia formation
Dynamic actin turnover drives lamellipodia extension during cell movement. Preclinical studies indicate that thymosin beta-4 and active LKKTET fragments promote endothelial cell migration and capillary sprouting in vitro. Reviewing batch documentation in our COA library confirms sequence length and chemical purity prior to cell culture testing.
Structural comparison between thymosin beta-4 and TB-500
Evaluating key chemical parameters clarifies the operational differences between these research compounds.
| Parameter | Thymosin beta-4 | TB-500 fragment |
|---|---|---|
| Sequence length | 43 amino acids | Truncated fragment (6–7 residues containing LKKTET) |
| Molecular weight | Approximately 4963 Da | Approximately 800–1000 Da |
| Biological origin | Endogenous mammalian protein | Fully synthetic peptide derivative |
| Actin-binding interface | Full 1:1 contact interface | Core LKKTET binding motif |
Researchers can explore our research peptide catalogue to access batch documentation for tissue research compounds.
Preclinical research applications in tissue models
Preclinical studies evaluate thymosin beta-4 and LKKTET fragments across various cell models, including corneal wound assays, dermal fibroblast migration, and cardiomyocyte survival signaling pathways. For further insight into analytical testing, read our guide on how to read a peptide certificate of analysis.
Differentiating thymosin beta-4 and TB-500 in research
Understanding the molecular differences between full-length thymosin beta-4 and synthetic TB-500 fragments ensures accurate experimental design in cell motility and actin dynamics research. High-purity verification supports reproducible preclinical findings. Available as research compounds with batch COA.
Frequently asked questions
Is synthetic TB-500 identical to full-length thymosin beta-4?
No, full-length thymosin beta-4 is an endogenous 43-amino acid protein with a molecular weight of approximately 4963 Da. TB-500 is a short synthetic peptide fragment containing the active LKKTET hexapeptide sequence, presenting a lower molecular weight while retaining core actin-binding properties.
What is the biological function of the LKKTET sequence motif?
The LKKTET sequence motif represents the active central binding site responsible for interacting with monomeric G-actin. By binding G-actin monomers, this sequence regulates actin polymerization dynamics, supporting cell motility and cytoskeletal remodeling in cell culture models.
How is sequence purity verified between full-length and fragment peptides?
High-performance liquid chromatography (HPLC) and high-resolution mass spectrometry (MS) differentiate full-length thymosin beta-4 from truncated fragments like TB-500. Mass spectrometry measures exact molecular weight, confirming whether the sample contains the full 43-amino acid sequence or the truncated hexapeptide fragment.
All Pepty Labs products are sold strictly for laboratory research use and are not intended for human or animal consumption.
